Literature DB >> 22965878

Folliculin interacts with p0071 (plakophilin-4) and deficiency is associated with disordered RhoA signalling, epithelial polarization and cytokinesis.

Michael S Nahorski1, Laurence Seabra, Ania Straatman-Iwanowska, Aileen Wingenfeld, Anne Reiman, Xiaohong Lu, Jeff A Klomp, Bin T Teh, Mechthild Hatzfeld, Paul Gissen, Eamonn R Maher.   

Abstract

Inherited mutations in the folliculin (FLCN) gene cause the Birt-Hogg-Dubé syndrome of familial hair follicle tumours (fibrofolliculomas), lung cysts and kidney tumours. Though folliculin has features of a tumour suppressor, the precise function of the FLCN gene product is not well characterized. We identified plakophilin-4 (p0071) as a potential novel folliculin interacting protein by yeast two-hybrid analysis. We confirmed the interaction of folliculin with p0071 by co-immunoprecipitation studies and, in view of previous studies linking p0071 to the regulation of rho-signalling, cytokinesis and intercellular junction formation, we investigated the effect of cell folliculin status on p0071-related functions. Folliculin and p0071 partially co-localized at cell junctions and in mitotic cells, at the midbody during cytokinesis. Previously, p0071 has been reported to regulate RhoA signalling during cytokinesis and we found that folliculin deficiency was associated with increased expression and activity of RhoA and evidence of disordered cytokinesis. Treatment of folliculin-deficient cells with a downstream inhibitor of RhoA signalling (the ROCK inhibitor Y-27632) reversed the increased cell migration phenotype observed in folliculin-deficient cells. Deficiency of folliculin and of p0071 resulted in tight junction defects and mislocalization of E-cadherin in mouse inner medullary collecting duct-3 renal tubular cells. These findings suggest that aspects of folliculin tumour suppressor function are linked to interaction with p0071 and the regulation of RhoA signalling.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22965878      PMCID: PMC3755511          DOI: 10.1093/hmg/dds378

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  41 in total

1.  Targeting of p0071 to desmosomes and adherens junctions is mediated by different protein domains.

Authors:  Mechthild Hatzfeld; Kathleen J Green; Helmut Sauter
Journal:  J Cell Sci       Date:  2003-04-01       Impact factor: 5.285

Review 2.  Rho and Rac take center stage.

Authors:  Keith Burridge; Krister Wennerberg
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

Review 3.  The p120 family of cell adhesion molecules.

Authors:  Mechthild Hatzfeld
Journal:  Eur J Cell Biol       Date:  2005-03       Impact factor: 4.492

4.  A 4-bp deletion in the Birt-Hogg-Dubé gene (FLCN) causes dominantly inherited spontaneous pneumothorax.

Authors:  Jodie N Painter; Hanna Tapanainen; Mirja Somer; Pentti Tukiainen; Kristiina Aittomäki
Journal:  Am J Hum Genet       Date:  2005-01-18       Impact factor: 11.025

5.  The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis.

Authors:  P H Maxwell; M S Wiesener; G W Chang; S C Clifford; E C Vaux; M E Cockman; C C Wykoff; C W Pugh; E R Maher; P J Ratcliffe
Journal:  Nature       Date:  1999-05-20       Impact factor: 49.962

6.  Fibrofolliculomas, tricodiscomas and acrochordons (Birt-Hogg-Dubé) associated with intestinal polyposis.

Authors:  F Rongioletti; R Hazini; G Gianotti; A Rebora
Journal:  Clin Exp Dermatol       Date:  1989-01       Impact factor: 3.470

Review 7.  Birt-Hogg-Dubé syndrome: diagnosis and management.

Authors:  Fred H Menko; Maurice A M van Steensel; Sophie Giraud; Lennart Friis-Hansen; Stéphane Richard; Silvana Ungari; Magnus Nordenskjöld; Thomas Vo Hansen; John Solly; Eamonn R Maher
Journal:  Lancet Oncol       Date:  2009-12       Impact factor: 41.316

8.  Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dubé syndrome.

Authors:  Michael L Nickerson; Michelle B Warren; Jorge R Toro; Vera Matrosova; Gladys Glenn; Maria L Turner; Paul Duray; Maria Merino; Peter Choyke; Christian P Pavlovich; Nirmala Sharma; McClellan Walther; David Munroe; Rob Hill; Eamonn Maher; Cheryl Greenberg; Michael I Lerman; W Marston Linehan; Berton Zbar; Laura S Schmidt
Journal:  Cancer Cell       Date:  2002-08       Impact factor: 31.743

9.  Cloning and characterization of a new armadillo family member, p0071, associated with the junctional plaque: evidence for a subfamily of closely related proteins.

Authors:  M Hatzfeld; C Nachtsheim
Journal:  J Cell Sci       Date:  1996-11       Impact factor: 5.285

10.  Induction of polarized cell-cell association and retardation of growth by activation of the E-cadherin-catenin adhesion system in a dispersed carcinoma line.

Authors:  M Watabe; A Nagafuchi; S Tsukita; M Takeichi
Journal:  J Cell Biol       Date:  1994-10       Impact factor: 10.539

View more
  23 in total

Review 1.  Molecular genetics and clinical features of Birt-Hogg-Dubé syndrome.

Authors:  Laura S Schmidt; W Marston Linehan
Journal:  Nat Rev Urol       Date:  2015-09-01       Impact factor: 14.432

Review 2.  Folliculin - A tumor suppressor at the intersection of metabolic signaling and membrane traffic.

Authors:  Mark P Dodding
Journal:  Small GTPases       Date:  2016-06-29

Review 3.  The Genetics of Pneumothorax.

Authors:  Philip M Boone; Rachel M Scott; Stefan J Marciniak; Elizabeth P Henske; Benjamin A Raby
Journal:  Am J Respir Crit Care Med       Date:  2019-06-01       Impact factor: 21.405

4.  Folliculin variants linked to Birt-Hogg-Dubé syndrome are targeted for proteasomal degradation.

Authors:  Lene Clausen; Amelie Stein; Martin Grønbæk-Thygesen; Lasse Nygaard; Cecilie L Søltoft; Sofie V Nielsen; Michael Lisby; Tommer Ravid; Kresten Lindorff-Larsen; Rasmus Hartmann-Petersen
Journal:  PLoS Genet       Date:  2020-11-02       Impact factor: 5.917

5.  Birt-Hogg-Dubé syndrome.

Authors:  Maria F Czyzyk-Krzeska; Francis X McCormack
Journal:  Fam Cancer       Date:  2013-09       Impact factor: 2.375

6.  Loss of FLCN inhibits canonical WNT signaling via TFE3.

Authors:  John C Kennedy; Damir Khabibullin; Thomas Hougard; Julie Nijmeh; Wei Shi; Elizabeth P Henske
Journal:  Hum Mol Genet       Date:  2019-10-01       Impact factor: 6.150

7.  Folliculin-interacting proteins Fnip1 and Fnip2 play critical roles in kidney tumor suppression in cooperation with Flcn.

Authors:  Hisashi Hasumi; Masaya Baba; Yukiko Hasumi; Martin Lang; Ying Huang; HyoungBin F Oh; Masayuki Matsuo; Maria J Merino; Masahiro Yao; Yusuke Ito; Mitsuko Furuya; Yasuhiro Iribe; Tatsuhiko Kodama; Eileen Southon; Lino Tessarollo; Kunio Nagashima; Diana C Haines; W Marston Linehan; Laura S Schmidt
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-16       Impact factor: 11.205

8.  Birt-Hogg-Dubé: tumour suppressor function and signalling dynamics central to folliculin.

Authors:  Andrew R Tee; Arnim Pause
Journal:  Fam Cancer       Date:  2013-09       Impact factor: 2.375

Review 9.  FLCN: The causative gene for Birt-Hogg-Dubé syndrome.

Authors:  Laura S Schmidt; W Marston Linehan
Journal:  Gene       Date:  2017-09-29       Impact factor: 3.688

10.  Clinical Features, Genetics and Potential Therapeutic Approaches for Birt-Hogg-Dubé Syndrome.

Authors:  Laura S Schmidt; W Marston Linehan
Journal:  Expert Opin Orphan Drugs       Date:  2014-11-29       Impact factor: 0.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.